Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons

Journal of Thoracic and Cardiovascular Surgery

Volumn 117, Issue 5, 1999, Pages 987-993

  Suzuki, Y ^a   Malekan, R ^a   Hanson III, C W ^a   Niewiarowski, S ^a   Sun, L ^a   Rao, A K ^a   Edmunds L H , Jr ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; NITRIC OXIDE; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE SLOWING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BABOON; BLEEDING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL SURGERY; HEMODYNAMIC MONITORING; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0032922683     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70380-6     Document Type: Article

References (29)

1. LH Edmunds Jr. Extracorporeal perfusion in cardiac surgery in the adult LH Edmunds Jr 1997 McGraw-Hill New York 255 294
2. RK Wenger H Lukasiewicz BS Mikuta S Niewiarowski LH Edmunds Jr. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass J Thorac Cardiovasc Surg 97 1989 235 239
3. CS Rinder JL Bonan HM Rinder J Mathew R Hines BR. Smith Cardiopulmonary bypass induces leukocyte-platelet adhesion Blood 79 1992 1201 1205
4. P Zilla R Fasol P Groscurth W Klepetko H Reichenspumer E. Wolner Blood platelets in cardiopulmonary bypass operations J Thorac Cardiovasc Surg 97 1989 379 388
5. S Miyamoto C Marcinkiewicz LH Edmunds Jr S. Niewiarowski Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/IIIa Thromb Haemost 80 1998 225 230
6. Y Hiramatsu N Gikakis HL Anderson JH Gorman C Marcinkiewicz RJ Gould Tirofiban provides “platelet anesthesia” during cardiopulmonary bypass in baboons J Thorac Cardiovasc Surg 113 1996 182 193
7. S Moncada RM Palmer EA. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
8. S Rimar CN. Gillis Selective pulmonary vasodilatation by inhaled nitric oxide is due to hemoglobin inactivation Circulation 88 1993 2884 2887
9. DR Phillips RM. Scarborough Clinical pharmacology of eptifibatide Am J Cardiol 80 1997 11B 20B
10. RM Scarborough JW Rose MA Naughton DR Phillips L Nannizzi A Arfsten Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms J Biol Chem 268 1993 1058 1065
11. Y Suzuki P Hillyer S Miyamoto S Niewiarowski L Sun AK Rao Integrilin prevents prolonged bleeding times after cardiopulmonary bypass Ann Thorac Surg 66 1998 373 381
12. A Bernabei N Gikakis MA Kowalska S Niewiarowski LH Edmunds Jr. Iloprost and echistatin protect platelets during simulated extracorporeal circulation Ann Thorac Surg 59 1995 149 153
13. Y Hiramatsu N Gikakis JH Gorman 3rd A baboon model for hematologic studies of cardiopulmonary bypass J Lab Clin Med 130 1997 412 420
14. VP Addonizio Jr JF Strauss III RW Colman LH Edmunds Jr. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator J Thorac Cardiovasc Surg 77 1979 119 126
15. 2+ on GP Ib-IIIa interactions with Integrilin Circulation 96 1997 1488 1494
16. AC Carvalho RW Colman RS. Lees Platelet function in hyperlipoproteinemia N Engl J Med 290 1974 434 438
17. B Rucinski S Niewiarowski P James DA Walz Z. Budzynski Antiheparin proteins secreted by human platelets: purification, characterization and radioimmunoassay Blood 53 1979 47 62
18. MW Radomski P Vallance G Whitley N Foxwell S. Moncada Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide Cardiovasc Res 27 1993 1380 1382
19. SB Sheth RW Colman Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design Semin Hematol 32 1995 110 119
20. GH Maurice RJ. Haslam Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP Mol Pharmacol 37 1990 671 681
21. H. Holmsen Platelet secretion and energy metabolism. RW Colman J Hirsch VJ Marder EW Salzman hemostasis and thrombosis: basic principles and clinical practice 3rd ed 1994 JB Lippincott Philadelphia 524 545
22. IF Charo RM Scarborough CP Mee D Wolf DR Phillips RL. Swift Pharmacodynamics of the GPIIb-IIIa antagonist Integrelin: phase I clinical studies in normal health volunteers [abstract] Circulation 86 Suppl 1992 I260
23. JH Chung N Gikakis TA Drake RW Colman LH Edmunds Jr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass Circulation 93 1996 2014 2018
24. K Mellgren G Mellgren S Lundin A Wennmalm H. Wadenvik Effect of nitric oxide gas on platelets during open heart operations Ann Thorac Surg 65 1998 1335 1341
25. K Mellgren LG Friberg G Mellgren T Hedner A Wennmalm H. Wadenvik Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion Ann Thorac Surg 61 1996 1194 1198
26. R Rossaint KF Falke R Lopez K Slama U Pison WM. Zapol Inhaled nitric oxide for the adult respiratory distress syndrome N Engl J Med 328 1993 399 405
27. WM Zapol S Rimar N. Gillis H Marletta CH. Bosken Nitric oxide and the lung: an NHLBI workshop summary Am J Respir Crit Care Med 149 1994 1375 1380
28. Anonymous Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy N Engl J Med 339 1998 436 443
29. MK Sly MD Prager RC Eberhart ME Jessen PV. Kulkarni Inhibition of surface-induced platelet activation by nitric oxide ASAIO J 41 1995 M394 M398